TY - CHAP M1 - Book, Section TI - Appendix: Formulary A1 - Dershwitz, Mark A1 - Rosow, Carl A2 - Longnecker, David E. A2 - Brown, David L. A2 - Newman, Mark F. A2 - Zapol, Warren M. Y1 - 2012 N1 - T2 - Anesthesiology, 2e AB - Table Graphic Jump LocationTable A-1 Analgesic AgentsView Table||Download (.pdf)Table A-1 Analgesic AgentsDrugRouteUsual DoseHow SuppliedFormCost*Oral COX InhibitorsAcetaminophenPO325-1000 mg325, 500 mgTablet0.01AspirinPO325-1000 mg325, 500 mgTablet0.05CelecoxibPO100-400 mg100 mg200 mg400 mgCapsuleCapsuleCapsule2.033.324.98Choline magnesium trisalicylatePO500-1000 mg500 mg1000 mgCapletCaplet0.350.86DiclofenacPO50-75 mg50 mg75 mgTabletTablet0.801.10DiflunisalPO500-1000 mg500 mgTablet0.66IbuprofenPO200-800 mg200 mg400 mg600 mg800 mgTabletTabletTabletTablet0.020.040.050.08IndomethacinPO25-50 mg25 mgCapsule0.04KetorolacPO10 mg10 mgTablet0.68NaproxenPO250-500 mg250 mg375 mg500 mgTabletTabletTablet0.100.080.08PiroxicamPOPO10-40 mg10 mg20 mgCapsuleCapsule0.090.11SulindacPO150 mg150 mgTablet0.33Oral OpioidsCodeinePO30-60 mg30 mg60 mgTabletTablet0.470.86Codeine/acetaminophenPO30-60 mg/300 mg30/300 mg60/300 mgTabletTablet0.470.75Hydrocodone/acetaminophenPO5-7.5 mg/500-1000 mg5 mg/500 mg7.5 mg/750 mgTabletTablet0.150.27HydromorphonePO2-4 mg¶2 mgTablet0.36LevorphanolPO2 mg¶2 mgTablet0.80MethadonePO10-20 mg¶10 mgTablet0.18MorphinePO30-60 mg30 mg2 mg/mL, 5 mLTabletSolution0.230.58Morphine sustained releasePO30-60 mg¶30 mgCaplet1.20OxycodonePO5-10 mg5 mgTablet0.26Oxycodone/acetaminophenPO5-10 mg/500-1000 mg5 mg/500 mgCaplet0.20Oxycodone sustained releasePO10-20 mg¶10 mg20 mg40 mg80 mgTabletTabletTabletTablet1.522.935.189.75TramadolPO50-100 mg50 mgTablet0.09Tramadol/acetaminophenPO75 mg/650 mgTablet0.77Transdermal and Transmucosal OpioidsFentanylTransdermal25-100 mcg/h25 mcg/h50 mcg/h75 mcg/h100 mcg/hPatchPatchPatchPatch9.7517.8127.1736.05FentanylTransbuccal200-1600 mcg200 mcg400 mcg800 mcgLozengeLozengeLozenge17.6725.6841.08Parenteral COX InhibitorsAcetaminophenIV1000 mg10 mg/mL, 10 mLSolution10.60KetorolacIVIM30 mg60 mg30 mg/mL, 1 mL30 mg/mL, 2 mLSolutionSolution1.001.07Parecoxib§IV/IM20-40 mg40 mgPowder§Parenteral OpioidsAlfentanilIV0.3-3 mcg/kg/min500 mcg/mL, 2 mL500 mcg/mL, 5 mLSolutionSolution3.877.25CodeineIV/IM30-60 mg30 mg/mL, 2 mLSolution2.18FentanylIV0.5-5 mcg/kg50 mcg/mL, 2 mL50 mcg/mL, 5 mL50 mcg/mL, 20 mLSolutionSolutionSolution0.530.722.70HydromorphoneIV/IM0.5-2 mg2 mg/mL, 1 mLSolution0.68MeperidineIV/IM/SC12.5-100 mg100 mg/mL, 1 mLSolution0.63MethadoneIV1-10 mg10 mg/mL, 20 mLSolution101.25MorphineIV/IM/SC1-10 mg10 mg/mL, 1 mLSolution0.57OxymorphoneIV/IM1.5 mg1 mg/mL, 1 mLSolution2.35RemifentanilIV0.01-1 mcg/kg/min1 mg2 mg5 mgPowderPowderPowder23.5844.6992.30SufentanilIV0.05-0.5 mcg/kg50 mcg/mL, 1 mL50 mcg/mL, 5 mLSolutionSolution3.1412.64Epidural OpioidsFentanyl‡EpiduralEpidural25-100 mcg1-4 mcg/mL, 5-10 mL/h50 mcg/mL, 2 mLSolution0.53Hydromorphone‡EpiduralEpidural0.75-1.5 mg10-100 mcg/mL, 5-10 mL/h2 mg/mL, 1 mLSolution0.68Meperidine†‡Epidural25-75 mg100 mg/mL, 1 mLSolution0.63MethadoneEpidural1-5 mg10 mg/mL, 20 mLSolution101.25MorphineEpidural2-5 mg0.5 mg/mL, 10 mLSolution, preservative-free9.83Morphine extended-release liposome injectionEpidural10-20 mg10 mg/mL, 1 mL10 mg/mL, 1.5 mLSolution, liposomalSolution, liposomal309.09463.64SufentanilEpidural20-50 mcg50 mcg/mL, 1 mLSolution3.14Intrathecal OpioidsFentanyl‡10-25 mcg50 mcg/mL, 2 mLSolution0.53Meperidine†‡10-20 mg100 mg/mL, 1 mLSolution0.63Morphine0.25-0.5 mg0.5 mg/mL, 10 mLSolution, preservative free9.83Sufentanil‡3-10 mcg50 mcg/mL, 1 mLSolution3.14Opioid Agonist/AntagonistsBuprenorphineIV0.3 mg0.3 mg/mL, 1 mLSolution2.52ButorphanolIV/IMNasal0.5-2 mg1-2 mg (1-2 sprays)2 mg/mL, 1 mL10 mg/mL, 2.5 mLSolutionSolution2.7059.45NalbuphineIV/IM5-10 mg10 mg/mL, 1 mLSolution1.50Opioid AntagonistsAlvimopanPO6-12 mg12 mgTablet56.25MethylnaltrexoneSC8-12 mg20 mg/mL, 0.6 mLSolution36.00NaloxoneIV/IM0.04-1 mg0.4 mg/mL, 1 mLSolution3.06NaltrexonePO50 mg50 mgTablet3.03Opioid AdjunctsCarbamazepinePO200-400 mg200 mgTablet0.08GabapentinPO300-1800 mg300 mgCapsule0.12PregabalinPO50-100 mg50 mgCapsule2.02*Reflects the cost to a hospital that is part of a large buying group for the size and form listed.†The required preservative-free preparation is generally not available in the United States.‡Not approved by the Food and Drug Administration for this indication in the United States.§An investigational agent in the United States.¶Much higher doses are commonly used in opioid-tolerant patients. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/10/06 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=56660417 ER -